Stock News - Citius Pharmaceuticals, Inc. $CTXR

Latest Stock News for $CTXR
Citius Pharmaceuticals' Subsidiary Citius Oncology Reports Positive Early Adoption of LYMPHIR™

Expected Stock impact: Noticeably Positive
2026-03-31 20:36:38